Glioma Malignant clinical trials

Explore recruiting glioma malignant clinical trials.

Recruiting glioma malignant studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Glioma Malignant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I/II multicenter study to assess efficacy and safety of ribociclib (LEE011) in combination with topotecan and temozolomide (TOTEM) in pediatric patients with relapsed or refractory neuroblastoma and other solid tumors

Spain, Germany, France, Denmark, Hungary, Czechia +1 more

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Glioma Malignant trials by city

Glioma Malignant in Toronto Glioma Malignant in Vancouver Glioma Malignant in Montreal Glioma Malignant in Calgary Glioma Malignant in Edmonton Glioma Malignant in Ottawa Glioma Malignant in Winnipeg Glioma Malignant in Quebec City Glioma Malignant in Hamilton Glioma Malignant in Kitchener Glioma Malignant in London Glioma Malignant in Halifax Glioma Malignant in New York Glioma Malignant in Los Angeles Glioma Malignant in Chicago Glioma Malignant in Houston

Glioma Malignant clinical trials

Recruiting glioma malignant studies right now

5G-PEARL: Paxalisib in Malignant Brain Tumours

Bevacizumab Versus Corticosteroids as First-line Treatment in Patients With Symptomatic Cerebral Radiation Necrosis After Radiation for High-grade Glioma or Brain Metastases

ASCENT Intervention for Brain Tumor Patients

TIL Therapy Combined With Pembrolizumab for Advanced Brain Cancer Including Gliomas and Meningiomas

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Magnetic Resonance (MR) Imaging to Determine High Risk Areas in Patients With Malignant Gliomas and to Design Potential Radiation Plans and to Examine Metabolite Changes in Gliomas and Other Solid Tumors

Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression

Retifanlimab With or Without Difluoromethylornithine for the Treatment of Progressive High Grade Gliomas

MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma

Clinical Study of Carbon Ion Radiotherapy for High-grade Glioma

Window of Opportunity Study of DSP-0390 in Gliomas

Injection of Active Allogeneic Natural Killer Cells in Patients With Gliomas

Also recruiting in Europe

Phase I/II multicenter study to assess efficacy and safety of ribociclib (LEE011) in combination with topotecan and temozolomide (TOTEM) in pediatric patients with relapsed or refractory neuroblastoma and other solid tumors

Glioma Malignant trials by city

Other conditions